Amgen (NQ: AMGN )
319.31
+1.16
(+0.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 25, 2024
Add to My Watchlist
Headline News about Amgen
![](https://g.foolcdn.com/editorial/images/708412/dividend-bank-roll.jpg)
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2022/november/recap/indexesnov8.jpg?sfvrsn=3530ad06_2)
![](https://www.investors.com/wp-content/uploads/2018/05/stock-Amgen-03-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/07/logo_light__558d5ea8f3221643a8794dc1c53bb8f1.png?width=1200&height=800&fit=crop)
Amgen's Olpasiran Reduced Cholesterol Levels In 95% Of Patients In Mid-Stage Study
November 07, 2022
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2019/08/stock-amgen-05-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6673.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_28892.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/04/elon_musktwitter.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/04/amgen_autoinjector_with_amgevita_by_amgen_adalimumab-6391.jpg?width=1200&height=800&fit=crop)
Amgen Reports Q3 Higher Profit, Despite Slight Fall In Topline Growth
November 04, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/706970/patient-talking-with-a-physician.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_20604.jpeg?width=1200&height=800&fit=crop)
![](https://public.newsdirect.com/711091570/2GeGkvFr.png)
![](https://g.foolcdn.com/editorial/images/704947/a-team-of-scientists-reviewing-results-in-a-lab.jpg)
Is Amgen Stock a Buy Now?
October 20, 2022
Via The Motley Fool
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_28900.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Via Benzinga
![](https://horanassoc.com/sites/default/files/styles/full/public/2022-10/dow%20dogs%2010%2028%202022.png?itok=kgRySrc5)
![](https://cdn.benzinga.com/files/images/story/2022/10/27/shutterstock_2213039957.jpg?width=1200&height=800&fit=crop)
![](https://fastgraphs.com/wp-content/uploads/2022/10/DowJones.png)
![](https://www.investors.com/wp-content/uploads/2021/07/Stock-Cytokinetics-01-shutt.jpg)
![](https://g.foolcdn.com/editorial/images/705709/a-customer-shops-at-a-pharmacy.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/valuestock_image_3419.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2022/10/A1MAIN_GeneEdit_102122.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_2223.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/704760/scientist-altering-dna-genome-project.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/14/aapharma_11.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.